Shilpa Medicare has achieved milestone by getting certification for the approval of Good Manufacturing Practices (GMP) for both Human Medicinal Products & Human Investigational Medicinal Products from Republic of Slovenia officials for its SEZ Formulation Unit situated at Jadcherla, Telengana which was inspected on November 19, 2014 by the authorities.
The company has also received certification for CEP 2004-201 Ambroxol Hydrochloride from European Directorate for the Quality of Medicines & Healthcare (EDQM). Earlier in March, EDQM inspected Shilpa Medicare’s 100 per cent EOU plant situated at Raichur.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1464.85 |
Dr. Reddys Lab | 5955.65 |
Cipla | 1477.15 |
Zydus Lifesciences | 1050.35 |
Lupin | 1603.55 |
View more.. |